Is acute stroke treatment heading towards a more endovascular approach?
Menon
Bijoy K
BK
Demchuk
Andrew M
AM
D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D004333:Drug Administration Routes; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007269:Injections, Intra-Arterial / Q000009:adverse effects / Q000706:statistics & numerical data; D007275:Injections, Intravenous / Q000706:statistics & numerical data; D020767:Intracranial Thrombosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D011183:Postoperative Complications / Q000209:etiology; D011859:Radiography; D020521:Stroke / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D015912:Thrombolytic Therapy / Q000379:methods* / Q000706:statistics & numerical data / Q000639:trends*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator